Purdue

Purdue Pharma Faces Intense Scrutiny as Bankruptcy Trustees Navigate Complex Mass Tort Litigation

by

Stamford, Conn.— Purdue Pharma, the company widely criticized for its role in the opioid crisis, has reached a critical juncture in its Chapter 11 bankruptcy proceedings that could significantly impact the landscape of mass tort litigation in the United States. Facing thousands of lawsuits, the pharmaceutical giant filed for bankruptcy in 2019 as part of an effort to settle claims alleging it fueled a national addiction epidemic with its aggressive marketing of the painkiller OxyContin. The latest proposal in Purdue Pharma’s bankruptcy case, which aims to resolve multitudes of opioid lawsuits, stipulates that the Sackler … Read more

Supreme Court Set to Deliver Landmark Verdict on Purdue Pharma Bankruptcy Amid Opioid Epidemic

by

Washington, D.C. – A pivotal decision is expected from the U.S. Supreme Court regarding the bankruptcy case of Purdue Pharma LP, as the nation continues grappling with an opioid crisis that has claimed over 750,000 lives to date. This ruling could herald a significant development in addressing the ramifications of one of the deadliest health emergencies in American history. Purdue Pharma, the maker of OxyContin, has been at the epicenter of lawsuits and public outcry, with numerous claims that the company aggressively marketed its highly addictive painkiller without proper warnings of its potential for abuse. … Read more

Supreme Court’s Latest Ruling on Purdue Case Redefines Legal Landscape for Mass Torts Defendants

by

Washington — In a landmark decision, the U.S. Supreme Court has issued a ruling that significantly affects the strategy of mass tort defendants, notably altering their range of options in legal proceedings. This pivotal ruling, centering on Purdue Pharma’s high-profile bankruptcy case, has implications for how large-scale legal actions against corporations may be structured in the future. The case arose from Purdue Pharma’s attempt to settle thousands of lawsuits tied to the opioid epidemic while filing for bankruptcy. Plaintiffs accused the company of aggressive marketing practices that contributed to widespread opioid addiction and deaths. In … Read more

Amid Purdue Pharma Legal Battles, Calls for Comprehensive Mass Tort Legislation Intensify

by

Washington – The recent Purdue Pharma ruling has reignited discussions on the urgent need for reform in the mass tort litigation system across the United States, spotlighting deep-seated issues impacting both plaintiffs and defendants. While specific cases, such as the opioid crisis lawsuits, bring to light individual corporate misconduct, they also underscore a wider systemic challenge that demands attention irrespective of single case outcomes. Mass tort cases involve lawsuits where numerous plaintiffs are directed against one or a few corporate defendants. Typically, these cases arise from claims where parties allege harm from products such as … Read more